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Thrombolysis and cardiopulmonary resuscitation:
TROICA — lost war or lost battle?
We would like to thank M. Koziński and J. Ku-
bica for their very interesting and important com-
ments [1]. We are happy that our article prompted
the expected discussion [2]. It was our intention to
show that thrombolytic therapy during cardiopul-
monary resuscitation goes beyond the previous log-
ic of applications in myocardial infarction, pulmo-
nary embolism and stroke. This form of therapy is
therefore directed not only to the possible cause of
non-traumatic cardiac arrest but first of all to com-
bating its effects.
It should be emphasised again that the idea of
the use of thrombolysis during cardiopulmonary re-
suscitation (CPR) results from theoretical premis-
es, initially verified experimentally, and since then,
albeit only recently, clinically [3]. Smaller non ran-
domised studies have shown the benefit of throm-
bolytic therapy. This is confirmed by the meta-anal-
ysis conducted [4]. It is as well to mention that the
clash of many projects, conceived on the basis of
pathophysiological knowledge and the resulting logic,
with the harsh reality of randomised tests, compli-
ant with evidence based medicine (EBM) principles,
often results in failure. The problem is that the ef-
fect obtained in the specified test, seen through the
prism of lack of influence on endpoints, does not nec-
essarily undermine the elements of prior theoreti-
cal and clinical knowledge, on the basis of which the
research project has been formulated.
The TROICA trial was prematurely halted, af-
ter preliminary findings indicated there were no
likely benefits of the treatment over placebo [5].
The results of the TROICA tests show that in pa-
tients to whom thrombolytic therapy was applied
during cardiopulmonary resuscitation differences in
the return of spontaneous circulation, hospital ad-
mission, 24-hour and 30-day survival, symptomat-
ic intracranial hemorrhage and major bleedings
were not statistically significant. This may be evi-
dence that the combating of disseminated throm-
bosis in small vessels after circulatory arrest by
means of the thrombolytic therapy assumed in the
protocol did not influence the endpoints described,
or that mistakes were made in the planning, meth-
odology or execution of the work or the evaluation
of results.
Why has thrombolytic therapy in TROICA test-
ing failed to bring about the anticipated benefits?
According to the protocol, patients in whom there
was a quick return of spontaneous circulation and
patients with asystole were excluded. Moreover, in
patients who needed prolonged CPR, blood flow
may have been insufficient to bring tenecteplase to
the thrombus. Also TNK-tPA interaction with met-
abolic conditionings such as acidosis, hyperglycemia
and the application of vasopressors were not taken
into consideration. It would also be advisable
to assess the late survivability of patients (after
12 months from ROSC) and their neurological state.
It is the increase in the late and not in the early
survival rate that is the basis for classification (class I)
and  the justification for the application of early cor-
onary angioplasty as the optimum method of pro-
cedure in acute coronary syndromes complicated by
cardiogenic shock [6, 7].
It is also worth emphasising that most of the
previous tests of the application of thrombolysis
during cardiopulmonary resuscitation were con-
ducted on the basis of streptokinase or alteplase
therapy. It emerges from the research of Stadlbau-
er et al. [8] that there is a higher hospital admis-
sion rate, but not a higher discharge rate, after the
application of thrombolysis in cardiac arrest in pa-
tients with worse baseline characteristics. This
points indirectly to the advantageous effects of
thrombolysis as a form of improvement of cardiop-
ulmonary resuscitation in susceptible patients.
The TROICA test demonstrates that thrombo-
lytic therapy should not be administered routinely
to cardiac arrest patients who need prolonged CPR.
On the basis of the literature studied so far we be-
lieve that the results of the TROICA test should not
put an end to discussion of this kind of therapy but
constitute the basis for a broader research perspec-
tive on whether interference with the functions of
the coagulation system in critically ill patients, in-
cluding those subject to cardiopulmonary resusci-
tation, is either necessary or possible.
Like M. Koziński and J. Kubica, we are sure
that subanalysis of the TROICA trial could be help-
ful in identifying patients who would benefit from
thrombolysis. To make a conclusive investigation
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of the efficacy of thrombolysis during cardiac arrest
a much larger study is required on the early use of
thrombolytics in patients with a relatively good
prognosis.
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